Keosys

Keosys is a specialized medical imaging company that provides comprehensive imaging core lab services and software solutions for clinical trials. Founded in 2001 and headquartered in France, the company supports pharmaceutical, biotech, and medical device sponsors by managing complex imaging data across global sites. Their flagship cloud-based platform, ViSION, enables secure image upload, automated quality control, and centralized independent review. Keosys focuses on therapeutic areas such as oncology, neurology, and cardiology, ensuring that imaging endpoints meet stringent regulatory requirements. In 2023, the company was acquired by Lumis International to expand its clinical trial service offerings.